Welcome to Part 2 of this learning activity titled, An NCDR Overview. After participation in this learning activity, the learner will be able to recite the history of NCDR and summarize NCDR participation around the world. NCDR launched its flagship registry, the CAF-PCI Registry, in 1998. The CAF-PCI Registry is a powerful tool which captures the data that measure adherence to ACC-AHA clinical practice guideline recommendations, procedure performance standards, and appropriate use criteria for coronary revascularization. Since its inception, the CAF-PCI Registry has grown nationally and internationally to include more than 1,700 member facilities. In 2005, the ICD Registry was created for the quality improvement needs and assessment of ICD and CRT-D device implants. The registry allowed hospitals across the nation to meet the Centers for Medicare and Medicaid Services requirement for reporting to a data registry based on their coverage determination. As of April of 2021, participating in the EP Device Implant, or informally known as the ICD Registry, is still your most reliable way to track ongoing compliance with the updated CMS National Coverage Determination, the NCD, which requires shared decision-making for primary prevention initial ICD implants. Independent of the CMS requirement, the EP Device Implant Registry continues to be your most trusted source of evidence-based data collection and reporting for ICD and CRT-D and now novel permanent pacemaker procedures. The EP Device Implant Registry plays an important role in determining the association between evidence-based treatment strategies and clinical outcomes. The CARE Registry was launched in 2006 and had since been enhanced to become the PVI Registry. The American College of Cardiology and Society for Vascular Surgeons have collaborated on a single vascular registry to harness the strengths of both organizations in improving care and outcomes of patients with vascular disease. Effective January 2021, the ACC's NCDR has collaborated with the SBS Vascular Quality Initiative to support and steer a single vascular registry. The ACTION Registry originally developed in 2007 and transitioned to the Chest Pain MI Registry in 2018. The Chest Pain MI Registry continues to be a trusted source for outcomes-based, continuous quality improvement for the STEMI and in-STEMI patients and now includes low-risk and unstable angina patients to help identify how to reduce variations in care. It helps hospitals apply American College of Cardiology and American Heart Association clinical guideline recommendations in their facilities and provides invaluable tools to measure care and achieve quality improvement goals. The registry fully supports the data requirements for ACC's Chest Pain Center Accreditation Program and offers a streamlined approach to achieve accreditation. The first of our outpatient registries was created in 2008 and was called the IC3 Registry. The branding had since been updated to the current registry now called the Pinnacle Registry and is now available through Veridigm. The registry provides a longitudinal view of the presentation, progression, management, and outcomes of patients with cardiovascular disease as they receive care and treatment from multidisciplinary care teams. The IMPACT Registry was launched in 2010 and assesses the prevalence, demographics, management, and outcomes of pediatric and adult congenital heart disease patients who undergo diagnostic catheterizations and catheter-based interventions. Its data support the development of evidence-based guidelines for CHD treatment that will improve outcomes for CHD patients of all ages. In 2012, the STS-ACC-TVT Registry became an initiative of the Society of Thoracic Surgeons and the American College of Cardiology Foundation with a mission to track patient safety and real-world outcomes related to transcatheter valve replacement or repair procedures for patients who are not eligible for conventional heart valve replacement or repair surgery. In its infancy, the registry began capturing this state-of-the-art transcatheter heart valve technology on the aortic valve before expanding into the mitral valve space and most recently the tricuspid space. The TVT Registry is backed by a breadth of expertise and resources, including the Federal Drug Administration, Centers for Medicare and Medicaid Services, and with input from the Society for Cardiovascular Angiography and Intervention and the American Association for Thoracic Surgery, making it well-positioned to help research, examine critical questions on the delivery and outcomes of eligible procedures. Similar to other registries, institutions can transparently display their commitment to continuous quality improvement through voluntary participation in the public reporting program, which helps institutions bridge gaps between science and clinical practice. In 2014, the second of NCDR's ambulatory registries was launched. The Diabetes Collaborative Registry was the first global, cross-specialty clinical registry designed to track and improve the quality of diabetes and metabolic care across the primary care and specialty care continuum. The Diabetes Registry is now available through Veridigm. In 2015, ACC's NCDR launched the LAAO Registry. The LAAO Registry captures data on left atrial appendage occlusion procedures to assess real-world procedural outcomes, short- and long-term safety, comparative effectiveness, and cost effectiveness. LAAO provides a treatment option to manage stroke risk for non-valvular atrial fibrillation patients who are unable to maintain adequate anticoagulation through medication therapy or are not good candidates for long-term treatment with anticoagulation. The LAAO Registry is approved by the Centers for Medicare and Medicaid Services to meet the registry requirements outlined in the National Coverage Decision for Percutaneous Left Atrial Appendage Closure. In 2016, the AFib Ablation Registry was launched. The AFib Ablation Registry assesses the prevalence, demographics, acute management, and outcomes of patients undergoing atrial fibrillation catheter-based ablation procedures. Its data will support the development of evidence-based guidelines for AFib treatments that will improve outcomes for patients. The value of NCDR registry participation is recognized by thousands of hospitals and private practices within the United States, but also by many global facilities throughout the world as well. All 50 states in the United States of America and Puerto Rico participate in the NCDR suite of data registries, and the following countries are also leading the field in global participation – Tanzania, Africa, Kenya, Africa, Canada, United Arab Emirates, Brazil, Pakistan, Thailand, India, Saudi Arabia, Australia, Vietnam, Israel, Argentina, Mexico, and Qatar. This list of countries will be expanding over time, and the current identified countries were participating as of January 2023. Thank you for participating in this learning activity titled, An NCDR Overview, Part 2. After participation in this learning activity, the learner should now be able to recite the history of NCDR and summarize NCDR participation around the world. Please advance to Part 3 of this four-part activity. Thank you. Thank you for participating in this learning activity titled, An NCDR Overview, Part 2.

NCDR Overview

National Cardiovascular Data Registry

Registries

Patient Outcomes

Quality of Care